Anteris Technologies Global Corp. (AVR) Stock Grade

About Anteris Technologies Global Corp.'s fundamentals

Anteris Technologies is a small-cap medical device company with a market capitalization of $117.6 million that experienced significant revenue headwinds, declining 29.2% year-over-year. The company posted a substantial net loss in its latest annual statement, resulting in a net margin of -4921.3%, indicating that expenses far exceeded revenues. The absence of profitability prevents meaningful calculation of traditional valuation metrics like the P/E ratio, and the company does not currently pay a dividend.